Back

Moderate anti-tumor effect of the nanoliposomal anti-PCSK9 vaccine in BALB/c mice bearing colorectal cancer.

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Cardio-oncology I Cardio-Oncology ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Maciej Banach

Medical University of Lodz, Lodz (Poland)

9 More presentations in this session

Presentation thumbnail
Doctor R. Kurmann (Rochester, US)
Abstract Slides
Presentation thumbnail
Assistant Professor S. Bae (Yongin, KR)
Abstract
Presentation thumbnail
Mrs I. Munoz Pousa (Vigo, ES)
Abstract Slides
Presentation thumbnail
Miss T. Daramola (Philadelphia, US)
Abstract Slides
Presentation thumbnail
Doctor A. Pardo Sanz (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Cardio-oncology I

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
GLP1-RA associated with PCSK9i as chemosensitizing method and therapy of anthracycline-induced cardiotoxicity under exposure to Ox-LDL: biochemical and preclinical evidences
20 June 2025
thumbnail
Congress Presentation
Effects of the activated coagulation factor X (FXa) and its protease-activated receptor-2 (PAR2) on colon cancer cell growth in vitro and in vivo
26 August 2023
thumbnail
Congress Presentation
Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial
1 September 2025
thumbnail
Congress Presentation
Indirect comparison of the safety and efficacy of alirocumab and evolocumab: from a comprehensive meta-analysis of 30 randomized controlled trials
3 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources